These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6762476)

  • 1. [Efficacy of guanfacine in the treatment of arterial hypertension].
    de Broucker D; Graux P; Dutoit A; Croccel L
    LARC Med; 1982; 2(7):613-5. PubMed ID: 6762476
    [No Abstract]   [Full Text] [Related]  

  • 2. [A clinical study of guanfacine in the treatment of arterial hypertension].
    Kheder A; Souilem J; Hassine L; Ben Maiz H; Ben Moussa F; Ben Ayed H
    Tunis Med; 1987 Nov; 65(11):709-12. PubMed ID: 3332951
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
    Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
    [No Abstract]   [Full Text] [Related]  

  • 4. [Guanfacine in the treatment of arterial hypertension. Apropos of 471 cases in a hospital milieu].
    Carette B
    Ann Cardiol Angeiol (Paris); 1984; 33(2):123-6. PubMed ID: 6143529
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO].
    Mayer K; Lupínek Z; Janousek S; Podrouzková B
    Cas Lek Cesk; 1984 Oct; 123(43):1306-11. PubMed ID: 6391673
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypertensive effectiveness of a guanfacine/clopamide combination].
    Wetzels E; Weidinger G
    MMW Munch Med Wochenschr; 1982 Oct; 124(40):871-4. PubMed ID: 6815503
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
    Joshi RC; De A; Cameron EG
    Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N; Knaup G
    Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
    [No Abstract]   [Full Text] [Related]  

  • 10. Examination of the antihypertensive action of long-term estulic (Egis-Sandoz) treatment.
    Zeher M; Antal L; Azad AQ; Szegedi G
    Ther Hung; 1988; 36(3):103-8. PubMed ID: 3074520
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypotensive and hemodynamic effects of guanfacine in arterial hypertension].
    Erina EV; Beliakova EV; Charyev KhZ; Panfilov VV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(1):63-7. PubMed ID: 2663029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 13. Guanfacine (Estulic) in the treatment of hypertension.
    Cor Vasa; 1987; 29(4 Suppl 1):1-52. PubMed ID: 3315446
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antihypertensive treatment with guanfacine in patients with type II diabetes mellitus].
    Coves MJ; Gomis R; Goday A; Casamitjana R; Rivera F; Vilardell E
    Med Clin (Barc); 1987 Feb; 88(8):315-7. PubMed ID: 3550310
    [No Abstract]   [Full Text] [Related]  

  • 15. [Improvement of the functional capacity of hypertensive patients treated with guanfacine].
    Bazika V; Neuzil P; Tiserová J; Hrabovský F
    Cas Lek Cesk; 1986 May; 125(21):637-40. PubMed ID: 3518943
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
    Rosenthal J; Jäger H
    MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
    Jerie P; Lasance A
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):170-4. PubMed ID: 6370876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
    Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract]   [Full Text] [Related]  

  • 19. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG; Bloxham CA; Walker JM
    Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A symposium: Guanfacine--a new choice in centrally acting antihypertensive agents. October 5-6, 1984, Scottsdale, Arizona.
    Am J Cardiol; 1986 Mar; 57(9):1E-61E. PubMed ID: 3513524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.